NovoCure To Present New Preclinical Data On Tumor Treating Fields At AACR Annual Meeting 2016
ST. HELIER, Jersey--(BUSINESS WIRE)--Novocure™ (NASDAQ: NVCR) will present three preclinical abstracts at the American Association for Cancer Research (AACR) Annual Meeting 2016 to be held April 16-20 in New Orleans. The abstracts highlight the latest understanding of the mechanism of action of Novocure’s novel cancer treatment, Tumor Treating Fields (TTFields).